The Conference Stage is the strategic core of LSLS 2026, delivering executive level keynotes, practitioner led panels and interactive discussions focused on shaping the future of IP and its intersection with prosecution, litigation, regulatory and competition law in the life sciences industry. Across two days, senior in house counsel, private practice leaders, regulators and judges will explore SPC strategy, patentability in the AI era, UPC and EPO updates, the EU Pharma Package and Biotech Act, competition enforcement trends, patent settlements, abuse of dominance, and key considerations in life science M&As and cross border transactions, providing nuanced debate and actionable insights for today’s most pressing legal challenges.
The Life Science Legal Strategy Hub is the central exhibition arena of LSLS 2026, uniting senior decision-makers across IP, regulation, competition and corporate law with law firms, legal technology vendors, data providers and consultancies in a carefully curated European marketplace, offering exhibitors direct access to in-house and external counsel seeking advanced solutions across IP prosecution, contracts, regulatory filings, due diligence, third-party risk, M&As and legal AI, alongside exclusive networking, curated lead generation and meaningful face-to-face engagement with active technology buyers.
